Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dexcom (DXCM)

Dexcom (DXCM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,017,084
  • Shares Outstanding, K 96,177
  • Annual Sales, $ 1,927 M
  • Annual Income, $ 493,600 K
  • 60-Month Beta 0.78
  • Price/Sales 17.78
  • Price/Cash Flow 92.56
  • Price/Book 18.73
Trade DXCM with:

Options Overview

Details
  • Implied Volatility 45.39%
  • Historical Volatility 33.70%
  • IV Percentile 7%
  • IV Rank 6.06%
  • IV High 121.43% on 03/18/20
  • IV Low 40.48% on 03/01/21
  • Put/Call Vol Ratio 1.47
  • Today's Volume 146
  • Volume Avg (30-Day) 1,958
  • Put/Call OI Ratio 2.25
  • Today's Open Interest 14,878
  • Open Int (30-Day) 20,163

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.31
  • Number of Estimates 12
  • High Estimate 0.50
  • Low Estimate 0.06
  • Prior Year 0.44
  • Growth Rate Est. (year over year) -29.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
347.23 +1.39%
on 03/05/21
423.40 -16.85%
on 02/19/21
-51.24 (-12.71%)
since 02/08/21
3-Month
329.60 +6.81%
on 12/09/20
423.40 -16.85%
on 02/19/21
+3.90 (+1.12%)
since 12/08/20
52-Week
182.07 +93.37%
on 03/17/20
456.23 -22.83%
on 08/07/20
+65.50 (+22.86%)
since 03/06/20

Most Recent Stories

More News
Keep Your Portfolio Protected From These Toxic Stocks

Toxic stocks are vulnerable to external shocks and are burdened with huge debts. It's important to ensure that you safeguard your portfolio from such stocks.

DXCM : 352.06 (-3.30%)
CWST : 62.76 (+0.77%)
HXL : 57.56 (+2.51%)
CDAY : 80.95 (-3.95%)
4 Toxic Stocks That Could Ruin Your Portfolio

Toxic stocks usually carry huge debt load and are vulnerable to external shocks. They should be timely discarded from one's portfolio to avoid wealth erosion.

DXCM : 352.06 (-3.30%)
HXL : 57.56 (+2.51%)
PAYC : 366.23 (-2.48%)
RCM : 24.65 (-2.26%)
Dexcom Announces Upcoming Virtual Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming virtual investor conferences:

DXCM : 352.06 (-3.30%)
DexCom (DXCM) Q4 Earnings Match Estimates, Revenues Beat

DexCom's (DXCM) fourth-quarter results benefit from domestic and international revenue growth.

ANGO : 21.29 (+1.09%)
HOLX : 70.91 (-1.99%)
DXCM : 352.06 (-3.30%)
ABT : 115.63 (-1.38%)
DexCom (DXCM) Meets Q4 Earnings Estimates

DexCom (DXCM) delivered earnings and revenue surprises of 0.00% and 1.88%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

DXCM : 352.06 (-3.30%)
Dexcom Launches Inaugural Venture Capital Fund

DexCom, Inc. (Nasdaq: DXCM), the global leader in continuous glucose monitoring for people with diabetes, today announced the launch of Dexcom Ventures. The inaugural fund will seek to identify and invest...

DXCM : 352.06 (-3.30%)
Dexcom Reports Fourth Quarter and Fiscal Year 2020 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2020.

DXCM : 352.06 (-3.30%)
Medical Products' Feb 11 Earnings Roster: DXCM, LH & More

The Medical Product companies' fourth-quarter results are likely to reflect huge adoption of COVID-19 related healthcare-support products and services despite the impact of the ongoing pandemic.

DXCM : 352.06 (-3.30%)
LH : 240.57 (+1.16%)
BIO : 554.11 (-2.43%)
AMWL : 21.61 (+1.27%)
DexCom (DXCM) to Report Q4 Earnings: What's in the Cards?

DexCom's (DXCM) fourth-quarter results are likely to reflect rising global awareness of its real-time CGM.

XRAY : 61.90 (+3.17%)
DXCM : 352.06 (-3.30%)
RDUS : 20.48 (-4.61%)
OPCH : 18.62 (-1.69%)
Dexcom and Nick Jonas Unveil First-Ever Super Bowl Commercial, Calling for Better Care for People With Diabetes

DexCom, Inc. (NASDAQ:DXCM), the global leader in continuous glucose monitoring for people with diabetes, debuted today its first-ever Super Bowl commercial, starring multi-platinum recording artist, actor...

DXCM : 352.06 (-3.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.

See More

Key Turning Points

3rd Resistance Point 381.28
2nd Resistance Point 374.12
1st Resistance Point 363.09
Last Price 352.06
1st Support Level 344.90
2nd Support Level 337.74
3rd Support Level 326.71

See More

52-Week High 456.23
Last Price 352.06
Fibonacci 61.8% 351.50
Fibonacci 50% 319.15
Fibonacci 38.2% 286.80
52-Week Low 182.07

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar